SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-002644
Filing Date
2024-01-31
Accepted
2024-01-31 13:13:27
Documents
19
Period of Report
2024-01-30
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K govx20240130_8k.htm   iXBRL 8-K 28646
2 EXHIBIT 3.1 ex_620739.htm EX-3.1 19313
3 EXHIBIT 4.1 ex_620740.htm EX-4.1 1701
8 a1.jpg GRAPHIC 540341
9 a2.jpg GRAPHIC 162976
  Complete submission text file 0001437749-24-002644.txt   1174539

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA govx-20240130.xsd EX-101.SCH 3851
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE govx-20240130_def.xml EX-101.DEF 13763
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE govx-20240130_lab.xml EX-101.LAB 18088
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE govx-20240130_pre.xml EX-101.PRE 13795
20 EXTRACTED XBRL INSTANCE DOCUMENT govx20240130_8k_htm.xml XML 4761
Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080 678-384-7220
GeoVax Labs, Inc. (Filer) CIK: 0000832489 (see all company filings)

IRS No.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39563 | Film No.: 24581860
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)